| USD millions | FY2023 | FY2024 | FY2025 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|
| Revenue | 10.9 | 0.3 | 3.4 | 1.5 | 2.7 | +76.2% | |
| Cost of revenue | 23.7 | 10.6 | 15.0 | 17.3 | 10.4 | −40.0% | |
| Gross profit | (12.8) | (10.2) | (11.6) | (15.8) | (7.7) | +51.2% | |
| Research & development | 3.4 | 8.3 | 6.6 | 3.3 | — | — | |
| Operating expenses | 20.3 | 32.5 | 41.1 | 43.4 | — | — | |
| Operating income | (33.1) | (42.8) | (0.0) | (1.0) | (5.6) | −475.1% | |
| Interest expense | — | — | — | 0.0 | 0.0 | — | |
| Interest income | — | — | — | 3.0 | 2.8 | −6.3% | |
| Pre-tax income | — | (0.0) | (0.0) | 2.1 | (12.4) | −701.6% | |
| Income tax | — | 0.0 | 0.0 | 0.6 | 0.6 | −4.8% | |
| Net income | (612.4) | (39.5) | (0.0) | 1.4 | (13.0) | −1013.0% | |
| EPS, basic (per share) | 0.00 | (0.01) | (0.01) | (0.02) | (1.30) | −6404.5% | |
| EPS, diluted (per share) | 0.00 | (0.01) | (0.01) | (0.02) | (1.30) | −6404.5% | |
| EBITDA | (31.9) | (40.4) | 1.0 | (0.4) | (5.6) | −1349.5% | |
| Depreciation & amortization | 1.2 | 2.4 | 1.1 | 0.6 | — | — | |
| Weighted average shares (shares) | 3,000,000,000 | 3,000,000 | 2,207,842 | 3,000,000 | — | — | |
| Weighted average diluted shares (shares) | 3,000,000,000 | 3,000,000 | 2,207,842 | 3,000,000 | — | — | |
| Gross margin | −117.8% | −2,968.6% | −343.3% | −1,043.6% | −289.1% | +754.5 pts | |
| Operating margin | −304.5% | −12,427.9% | −0.8% | −64.2% | −209.6% | −145.3 pts | |
| Net margin | −5,634.8% | −11,490.1% | −0.8% | 94.3% | −488.3% | −582.6 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
